Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Johnston, Tom H.
6260  Ergebnisse:
Personensuche X
?
1

Using artificial intelligence to identify drugs for repurpo..:

Johnston, Tom H. ; Lacoste, Alix M.B. ; Ravenscroft, Paula...
Neuropharmacology.  248 (2024)  - p. 109880 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Toward in vivo proof of binding of 18F-labeled inhibitor [1..:

Wuest, Melinda ; Bailey, Justin J. ; Dufour, Jennifer...
EJNMMI Research.  12 (2022)  1 - p. , 2022
Link: https://doi.org/10.1186/..
 
?
3

A novel dopamine D3R agonist SK609 with norepinephrine tran..:

Schneider, Jay S. ; Marshall, Courtney A. ; Keibel, Lauren...
Experimental Neurology.  335 (2021)  - p. 113514 , 2021
Link: https://doi.org/10.1016/..
 
?
4

Repurposing drugs to treat l-DOPA-induced dyskinesia in Par..:

Johnston, Tom H. ; Lacoste, Alix M.B. ; Visanji, Naomi P....
Neuropharmacology.  147 (2019)  - p. 11-27 , 2019
Link: https://doi.org/10.1016/..
 
?
5

Pridopidine, a clinic‐ready compound, reduces 3,4‐dihydroxy..:

Johnston, Tom H. ; Geva, Michal ; Steiner, Lilach...
Movement Disorders.  34 (2018)  5 - p. 708-716 , 2018
Link: https://doi.org/10.1002/..
 
?
6

DPI-289, a novel mixed delta opioid agonist / mu opioid ant..:

Johnston, Tom H. ; Versi, Eboo ; Howson, Patrick A....
Neuropharmacology.  131 (2018)  - p. 116-127 , 2018
Link: https://doi.org/10.1016/..
 
?
7

Towards a Non-Human Primate Model of Alpha-Synucleinopathy ..:

Koprich, James B. ; Johnston, Tom H. ; Reyes, Gabriela...
PLOS ONE.  11 (2016)  11 - p. e0167235 , 2016
Link: https://doi.org/10.1371/..
 
?
8

Pioglitazone may impair L‐DOPA anti‐parkinsonian efficacy i..:

Huot, Philippe ; Johnston, Tom H. ; Fox, Susan H..
Synapse.  69 (2015)  3 - p. 99-102 , 2015
Link: https://doi.org/10.1002/..
 
?
9

The highly-selective 5-HT1A agonist F15599 reduces l-DOPA-i..:

Huot, Philippe ; Johnston, Tom H. ; Fox, Susan H...
Neuropharmacology.  97 (2015)  - p. 306-311 , 2015
Link: https://doi.org/10.1016/..
 
?
10

Reproducibility of a Parkinsonism-related metabolic brain n..:

Ma, Yilong ; Johnston, Tom H. ; Peng, Shichun...
Movement Disorders.  30 (2015)  9 - p. 1283-1288 , 2015
Link: https://doi.org/10.1002/..
 
?
11

UWA-121, a mixed dopamine and serotonin re-uptake inhibitor..:

Huot, Philippe ; Johnston, Tom H. ; Lewis, Katie D....
Neuropharmacology.  82 (2014)  - p. 76-87 , 2014
Link: https://doi.org/10.1016/..
 
?
12

Alternating Hemiplegia of Childhood-Related Neural and Beha..:

Kirshenbaum, Greer S. ; Dawson, Neil ; Mullins, Jonathan G. L....
PLoS ONE.  8 (2013)  3 - p. e60141 , 2013
Link: https://doi.org/10.1371/..
 
?
13

RGFP109, a histone deacetylase inhibitor attenuates l-DOPA-..:

Johnston, Tom H. ; Huot, Philippe ; Damude, Sammie...
Parkinsonism & Related Disorders.  19 (2013)  2 - p. 260-264 , 2013
Link: https://doi.org/10.1016/..
 
?
14

Rotigotine polyoxazoline conjugate SER‐214 provides robust ..:

Eskow Jaunarajs, Karen L. ; Standaert, David G. ; Viegas, Tacey X....
Movement Disorders.  28 (2013)  12 - p. 1675-1682 , 2013
Link: https://doi.org/10.1002/..
 
?
15

Use of catechol‐O‐methyltransferase inhibition to minimize ..:

Huot, Philippe ; Johnston, Tom H. ; Snoeren, Tessa...
European Journal of Neuroscience.  37 (2013)  5 - p. 831-838 , 2013
Link: https://doi.org/10.1111/..
 
1-15